Nationwide COVID-19 vaccination coverage and COVID-19 incidence in South Korea, January 2022: a national official report

  • Kim S
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Objective: To reduce the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, severe coronavirus disease 2019 (COVID-19) illness, and COVID-19 related death, all persons in South Korea should stay up to data with recommended COVID-19 vaccinations. This study investigated the rates and effectiveness of the COVID-19 vaccination in reducing the severity of disease of the entire Korean population. Methods: On January 2022, the official data released by the Korea Disease Control and Prevention Agency was analyzed. The types of COVID-19 vaccines (ChAdOx1-S [AstraZeneca], BNT162b2 [Pfizer-BioNTech], mRNA-1273 [Moderna], and Ad26.COV2.S [Janssen]), the cumulative cases, and the incidences of COVID-19 were estimated. The relative risk reduction of the severe COVID-19 cases was analyzed according to the histories of the COVID-19 vaccination. Results: On January 2022, the cumulative number of patients with COVID-19 cases was 642,207, with the incidence rate of 1,239 per 1,000,000 people. 82.22% [42,219,818/51,349,116] of Koreans have successfully been vaccinated two doses and 36.42% [13,709,545/51,349,116] were vaccinated a booster dose of the COVID-19. The relative risk reduction of severe COVID-19 was 27% (95% confidence interval [95% CI], 24 to 30) for the second dose of the COVID-19 vaccine and 79% (95% CI, 66 to 87) for the booster dose of the COVID-19 vaccine. In the ≥75 years old age group, the relative risk reduction of severe COVID-19 cases was 0.71 (95% CI, 0.69 to 0.73) for the second dose of COVID-19 vaccine and 0.99 (95% CI, 0.99 to 1.00) for the booster dose of COVID-19 vaccine. Conclusion: A maximum of high as 82.22% of Korean has been vaccinated two doses for COVID-19 until by January 2022. The COVID-19 vaccination was effective for reducing the severity of the COVID-19 in Korea. In addition, the preventive effect of COVID-19 vaccine for severe COVID-19 cases was high in old population.

Cite

CITATION STYLE

APA

Kim, S. Y. (2022). Nationwide COVID-19 vaccination coverage and COVID-19 incidence in South Korea, January 2022: a national official report. Life Cycle, 2. https://doi.org/10.54724/lc.2022.e2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free